State-of-the-Art Molecular Oncology in Brazil.
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 May 2023
29 May 2023
Historique:
received:
18
04
2023
accepted:
11
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Over the past few decades, the life expectancy of humankind has increased significantly due to advancements in life sciences and medical research, particularly given our increasing success in the epidemiological and pharmacological management of bacterial, fungi, and viral infections [...].
Identifiants
pubmed: 37298404
pii: ijms24119452
doi: 10.3390/ijms24119452
pmc: PMC10253574
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Mol Sci. 2022 Jul 23;23(15):
pubmed: 35897681
Pharmacol Res. 2016 Sep;111:102-112
pubmed: 27265114
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Mol Sci. 2022 Oct 03;23(19):
pubmed: 36233023
Int J Mol Sci. 2022 Jul 14;23(14):
pubmed: 35887120
Int J Mol Sci. 2022 Dec 08;23(24):
pubmed: 36555156
Int J Oncol. 2019 Feb;54(2):407-419
pubmed: 30570109
Int J Mol Sci. 2022 May 13;23(10):
pubmed: 35628256
Int J Mol Sci. 2022 Jun 26;23(13):
pubmed: 35806108
Int J Mol Sci. 2022 Oct 07;23(19):
pubmed: 36233212
Int J Mol Sci. 2023 Feb 20;24(4):
pubmed: 36835617
Int J Mol Sci. 2022 Apr 25;23(9):
pubmed: 35563133
Life (Basel). 2022 Sep 23;12(10):
pubmed: 36294912
Cancers (Basel). 2023 Mar 17;15(6):
pubmed: 36980699
Int J Mol Sci. 2022 Jul 05;23(13):
pubmed: 35806488
Nat Rev Clin Oncol. 2023 Apr;20(4):211-228
pubmed: 36721024